XML 21 R9.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue
 6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
The following table presents the Company’s disaggregated revenue by offering type (in thousands):
 Three Months Ended
June 30,
 20242023
 
Total Net
Revenues
Percentage of
Total Net
Revenues
Total Net
Revenues
Percentage of
Total Net
Revenues
Patient Services revenue recognized at a point in time:
Direct products$730 2.2 %$578 1.8 %
Third-Party Payer products3,695 11.0 %3,365 10.6 %
Patient Services revenue recognized over time:
Direct rental services1,928 5.7 %1,865 5.9 %
Third-Party Payer rental services11,889 35.3 %10,889 34.3 %
Total Patient Services accounted for under ASC 60618,242 54.1 %16,697 52.6 %
Device Solutions revenue recognized at a point in time:
Products3,943 11.7 %3,866 12.2 %
Services
2,457 7.3 %2,459 7.7 %
Device Solutions revenue recognized over time:
Services
2,040 6.1 %1,499 4.7 %
Total Device Solutions accounted for under ASC 6068,440 25.0 %7,824 24.7 %
Total Revenue Accounted for under ASC 60626,682 79.2 %24,521 77.3 %
Patient Services lease revenue
2,004 5.9 %2,622 8.3 %
Device Solutions lease revenue
5,012 14.9 %4,592 14.5 %
Total Revenue accounted for under ASC 842, Leases7,016 20.8 %7,214 22.7 %
Total Net Revenue$33,698 100.0 %$31,735100.0 %
 Six Months Ended
June 30,
 20242023
 
Total Net
Revenues
Percentage of
Total Net
Revenues
Total Net
Revenues
Percentage of
Total Net
Revenues
Patient Services revenue recognized at a point in time:
Direct products$1,345 2.0 %$1,157 1.9 %
Third-Party Payer products7,267 11.1 %6,773 10.9 %
Patient Services revenue recognized over time:
Direct rental services3,800 5.8 %3,734 6.0 %
Third-Party Payer rental services22,866 34.8 %21,910 35.3 %
Total Patient Services accounted for under ASC 60635,278 53.7 %33,574 54.1 %
Device Solutions revenue recognized at a point in time:
Products8,155 12.4 %7,606 12.2 %
Services4,867 7.4 %5,035 8.1 %
Device Solutions revenue recognized over time:
Services4,009 6.1 %2,272 3.7 %
Total Device Solutions accounted for under ASC 60617,031 25.9 %14,913 24.0 %
Total Revenue Accounted for under ASC 60652,309 79.6 %48,487 78.1 %
Patient Services Lease Revenue3,559 5.4 %4,519 7.3 %
Device Solutions Lease Revenue9,825 15.0 %9,099 14.7 %
Total Revenue accounted for under ASC 842, Leases13,384 20.4 %13,618 21.9 %
Total Net Revenue$65,693 100.0 %$62,105100.0 %
Contract Balances
(dollars in thousands)
As of June 30, 2024
As of December 31, 2023
$ Change
Accounts receivable, net$21,325 $19,830 $1,495 
Contract assets$1,271 $1,271 $— 
There was no change in the balance for contract assets during the six months ended June 30, 2024. The activity related to the contract assets during the six months ended June 30, 2024 included $5.6 million of revenue recognized for which the payment is subject to conditions other than the passage of time, which was fully offset by $5.6 million of contract assets reclassified to accounts receivable as our right to consideration for these contract assets became unconditional. Contract assets are included in other current assets on the Company's Condensed Consolidated Balance Sheets.